Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Skye Bioscience Uplists to The Nasdaq Global Market
Read Article
News
2024
2023
Archive
Search news articles
November 16, 2021
Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan
November 10, 2021
Crinetics Pharmaceuticals Presenting New Data From Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES Congress
November 10, 2021
Nouscom to Present Interim Data From Phase 1 Trial Evaluating NOUS-209, an “Off-The-Shelf” Neoantigen Cancer Vaccine for the Treatment of MSI-H Solid Tumors
November 10, 2021
Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List
November 10, 2021
Novome Biotechnologies and Genentech Enter into a Strategic Collaboration to Develop Targets Against Inflammatory Bowel Disease
November 8, 2021
Akouos Appoints Stacy Price as Chief Technical Officer
November 4, 2021
NodThera Announces Progress of NT-0796, a Novel NLRP3 Inflammasome Inhibitor, into a Phase 1 First-in-Human Study
November 2, 2021
Cabaletta Bio Reports Clinical Data from the Third Dose Cohort in DesCAARTes™ Trial in Patients with mPV
October 29, 2021
Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering
October 28, 2021
Ensoma Strengthens Scientific Advisory Board with Leaders in Oncology and Primary Immune Deficiencies
« Previous Page
1
2
3
4
…
16
Next Page »